Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOMILNACIPRAN Cause Blood pressure increased? 36 Reports in FDA Database

Sharpen Your Memory & Focus Naturally

NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.

Boost Your Brain

According to the FDA Adverse Event Reporting System (FAERS), 36 reports of Blood pressure increased have been filed in association with LEVOMILNACIPRAN (Fetzima). This represents 2.6% of all adverse event reports for LEVOMILNACIPRAN.

36
Reports of Blood pressure increased with LEVOMILNACIPRAN
2.6%
of all LEVOMILNACIPRAN reports
1
Deaths
7
Hospitalizations

How Dangerous Is Blood pressure increased From LEVOMILNACIPRAN?

Of the 36 reports, 1 (2.8%) resulted in death, 7 (19.4%) required hospitalization, and 2 (5.6%) were considered life-threatening.

Is Blood pressure increased Listed in the Official Label?

Yes, Blood pressure increased is listed as a known adverse reaction in the official FDA drug label for LEVOMILNACIPRAN.

What Other Side Effects Does LEVOMILNACIPRAN Cause?

Off label use (376) Drug ineffective (315) Gastrooesophageal reflux disease (295) Vomiting (294) Hypoaesthesia (290) Abdominal pain upper (285) Paraesthesia (282) Memory impairment (277) Blepharospasm (276) Taste disorder (276)

What Other Drugs Cause Blood pressure increased?

RITUXIMAB (4,185) INFLIXIMAB (2,997) CABOZANTINIB S-MALATE (2,939) OCTREOTIDE (2,799) OMALIZUMAB (2,678) TOCILIZUMAB (2,490) METHOTREXATE (2,486) NIRAPARIB (2,464) INFLIXIMAB-DYYB (2,309) AMLODIPINE (2,282)

Which LEVOMILNACIPRAN Alternatives Have Lower Blood pressure increased Risk?

LEVOMILNACIPRAN vs LEVONORGESTREL LEVOMILNACIPRAN vs LEVORPHANOL LEVOMILNACIPRAN vs LEVOSIMENDAN LEVOMILNACIPRAN vs LEVOSULPIRIDE LEVOMILNACIPRAN vs LEVOTHYROXINE

Related Pages

LEVOMILNACIPRAN Full Profile All Blood pressure increased Reports All Drugs Causing Blood pressure increased LEVOMILNACIPRAN Demographics